一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Advanced Science >>article
Advanced Science

Advanced Science

IF: 14.3
Download PDF

Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

Published:3 November 2024 DOI: 10.1002/advs.202406714 PMID: 39488785
Ying-Qin Zhu, Yue Huang, Yin-Hao Shi, Chen-Song Huang, Guang-Yin Zhao, Zhi-De Liu, Ming-Jian Ma, Jing-Yuan Ye, Xiang Xu, Qi Liu, Xi-Tai Huang, Jie-Qin Wang, Qiong-Cong Xu, Xiao-Yu Yin

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with a dismal prognosis. Gemcitabine-based chemotherapy has emerged as a first-line treatment for PDAC. However, the development of gemcitabine resistance often results in therapeutic failure. In order to uncover the underlying mechanisms of gemcitabine resistance, gemcitabine-resistant PDAC cell lines and patient-derived xenograft (PDX) models are established and subjected to RNA sequencing. It is found that CMTM6 is closely related to gemcitabine resistance in PDAC. Multi-omics analysis revealed that EP300-mediated H3K27ac modification is involved in the transcriptional activation of CMTM6, which maintains IGF2BP1 expression by preventing its ubiquitination. The m6A reader IGF2BP1 stabilizes the EP300 and MYC mRNAs by recognizing m6A modifications, forming a positive feedback loop that enhances tumor stemness and ultimately contributes to PDAC resistance. The combined application of the EP300 inhibitor inobrodib and gemcitabine exerts a synergistic effect on PDAC. Overall, these findings reveal that the EP300–CMTM6–IGF2BP1 positive feedback loop facilitates gemcitabine resistance via epigenetic reprogramming and the combined use of inobrodib and gemcitabine represents a promising strategy for overcoming chemoresistance in PDAC, warranting further investigation in clinical trials.

Substances (10)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Gemcitabine hydrochloride 122111-03-9 C9H11F2N3O4.ClH 780 suppliers $4.00-$8990.00
Gemcitabine hydrochloride 122111-03-9 C9H11F2N3O4.ClH 780 suppliers $4.00-$8990.00
Gemcitabine hydrochloride 122111-03-9 C9H11F2N3O4.ClH 780 suppliers $4.00-$8990.00
Gemcitabine hydrochloride 122111-03-9 C9H11F2N3O4.ClH 780 suppliers $4.00-$8990.00
Gemcitabine 122111-03-9 - Inquiry
Gemcitabine 122111-03-9 - Inquiry
Gemcitabine HCl 122111-03-9 - Inquiry
Gemcitabine HCl 122111-03-9 - Inquiry
Gemcitabine hydrochloride 122111-03-9 - Inquiry
Gemcitabine hydrochloride 122111-03-9 - Inquiry

Similar articles

IF:3.8

Oxaliplatin in perioperative chemotherapy for gastric and gastroesophageal junction (GEJ) adenocarcinoma.

Expert Review of Gastroenterology & Hepatology Ralph Fritsch, Jens Hoeppner,etc Published: 1 April 2019
IF:5.5

Inhibition of Non-specific Amplification in Loop-Mediated Isothermal Amplification via Tetramethylammonium Chloride.

BioChip Journal MinJu Jang, Sanghyo Kim,etc Published: 1 January 2022
IF:13.3

Ethyl oleate synthesis by Porcine pancreatic lipase in organic solvents

Chemical Engineering Journal S. Hazarika , P. Goswami ,etc Published: 15 January 2002
甘德县| 琼海市| 罗平县| 安西县| 闻喜县| 砀山县| 新巴尔虎右旗| 瑞金市| 建始县| 新宁县| 久治县| 赤水市| 临江市| 晴隆县| 神农架林区| 神农架林区| 南安市| 环江| 平昌县| 东乡族自治县| 沾益县| 工布江达县| 金乡县| 新密市| 禄丰县| 临夏县| 从化市| 江津市| 丰台区| 南通市| 塔河县| 灵璧县| 新乐市| 汉阴县| 温泉县| 乃东县| 美姑县| 文登市| 边坝县| 习水县| 西藏|